NCT03806140View on ClinicalTrials.gov

Development and Evaluation of THRIVE

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 1, 2014

Primary Completion Date

January 1, 2016

Study Completion Date

January 1, 2016

Conditions
Oncology
Interventions
BEHAVIORAL

text messages

receive about one health-related text message a day for 16 weeks

All Listed Sponsors
lead

Children's Hospital of Philadelphia

OTHER

NCT03806140 - Development and Evaluation of THRIVE | Biotech Hunter | Biotech Hunter